Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.31 MYR Market Closed
Market Cap: 2B MYR
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
+91%
5Y
-
10Y
-
Investing Cash Flow
+
3Y
-142%
5Y
-343%
10Y
-156%
Financing Cash Flow
+
3Y
+99%
5Y
-
10Y
+831%

Cash Flow Statement
Pharmaniaga Bhd

Rotate your device to view
Cash Flow Statement
Currency: MYR
Dec-2002 Mar-2003 Jun-2003 Sep-2003 Dec-2003 Mar-2004 Jun-2004 Sep-2004 Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Jun-2006 Sep-2006 Dec-2006 Mar-2007 Jun-2007 Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Taxes Paid
(27)
(23)
(26)
(21)
(16)
(15)
(14)
(16)
(17)
(18)
(18)
(18)
(21)
(20)
(19)
(16)
(12)
(10)
(9)
(9)
(20)
(26)
(28)
(34)
(32)
(33)
(36)
(33)
(28)
(26)
(26)
(27)
(24)
(22)
(21)
(21)
(24)
(28)
(26)
(30)
(36)
(39)
(41)
(40)
(34)
(29)
(21)
(18)
(21)
(21)
(30)
(33)
(36)
(38)
(37)
(34)
(26)
(27)
(25)
(24)
(20)
(13)
(13)
(9)
(17)
(18)
(19)
(17)
(13)
4
6
3
(5)
(24)
(21)
(31)
(64)
(70)
(85)
(82)
(40)
(33)
(21)
(13)
(21)
(20)
(22)
(28)
(34)
(40)
(43)
(53)
Cash Interest Paid
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(4)
(6)
(5)
(6)
(6)
(6)
(6)
(6)
(5)
(5)
(4)
(4)
(4)
(4)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(5)
(6)
(7)
(19)
(22)
(24)
(26)
(16)
(16)
(14)
(15)
(17)
(16)
(19)
(21)
(16)
(18)
(21)
(23)
(32)
(32)
(30)
(29)
(29)
(30)
(32)
(34)
(37)
(39)
(41)
(41)
(38)
(37)
(40)
(41)
(39)
(38)
(32)
(30)
(33)
(35)
(40)
(45)
(41)
(45)
(48)
(50)
(61)
(64)
(72)
(69)
(68)
(68)
(64)
(64)
Change in Working Capital
65
46
34
19
86
78
114
104
129
87
61
40
(3)
57
13
(3)
45
9
72
139
91
165
93
157
218
160
210
134
107
91
106
80
102
77
55
31
(38)
57
43
52
1
(5)
(16)
16
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
1
1
1
1
1
1
1
2
2
2
2
2
3
Cash from Operating Activities
35
N/A
20
-44%
5
-76%
(5)
N/A
68
N/A
60
-11%
98
+62%
86
-13%
110
+29%
67
-40%
41
-38%
20
-51%
(27)
N/A
34
N/A
(11)
N/A
(24)
-132%
28
N/A
(8)
N/A
56
N/A
125
+121%
65
-48%
134
+106%
60
-56%
118
+98%
182
+54%
123
-33%
170
+39%
97
-43%
76
-22%
61
-19%
76
+25%
49
-36%
74
+51%
51
-31%
29
-43%
7
-78%
(65)
N/A
(14)
+78%
(27)
-87%
(23)
+13%
17
N/A
62
+273%
115
+85%
161
+39%
250
+56%
201
-20%
135
-33%
166
+23%
213
+29%
95
-55%
52
-46%
17
-67%
7
-56%
1
-86%
54
+5 340%
50
-9%
35
-29%
218
+515%
231
+6%
209
-10%
239
+14%
(12)
N/A
(20)
-66%
(42)
-110%
(82)
-97%
181
N/A
106
-41%
176
+66%
190
+8%
46
-76%
111
+142%
44
-61%
(26)
N/A
(30)
-17%
(356)
-1 085%
37
N/A
(64)
N/A
32
N/A
214
+571%
(105)
N/A
(142)
-36%
(218)
-53%
37
N/A
(14)
N/A
47
N/A
57
+22%
(60)
N/A
(33)
+45%
43
N/A
120
+182%
128
+6%
(9)
N/A
Investing Cash Flow
Capital Expenditures
(24)
(27)
(6)
(2)
(23)
(21)
(21)
(25)
(15)
(20)
(21)
(30)
(51)
(61)
(86)
(83)
(68)
(62)
(36)
(26)
(27)
(21)
(23)
(25)
(21)
(18)
(14)
(13)
(32)
(33)
(36)
(33)
(7)
(7)
(10)
(25)
(31)
(33)
(30)
(16)
(23)
(24)
(31)
(32)
(44)
(45)
(39)
(49)
(31)
(28)
(31)
(50)
(61)
(67)
(68)
(40)
(44)
(45)
(42)
(40)
(29)
(20)
(20)
(23)
(18)
(18)
(16)
(15)
(20)
(22)
(20)
(19)
(9)
(15)
(16)
(17)
(30)
(42)
(50)
(57)
(59)
(43)
(41)
(45)
(63)
(68)
(64)
(55)
(31)
(28)
(26)
(30)
Other Items
0
0
0
(4)
(21)
(21)
(21)
(1)
(8)
(87)
(87)
(87)
(84)
(13)
(22)
(22)
13
13
21
21
0
0
0
1
1
7
28
35
56
49
29
22
1
1
1
6
(101)
(150)
(190)
(205)
(105)
(78)
(48)
(43)
(36)
(78)
(75)
(118)
(123)
(62)
(60)
(26)
(58)
(92)
(99)
(98)
(103)
(71)
(70)
(63)
(33)
(28)
(25)
(42)
(59)
(67)
(62)
(57)
(52)
(46)
(44)
(25)
(23)
(24)
(22)
(22)
(15)
(15)
(19)
(23)
(13)
(12)
(8)
(7)
(5)
(11)
(16)
(14)
(14)
(7)
(5)
(164)
Cash from Investing Activities
(24)
N/A
(24)
+1%
10
N/A
(6)
N/A
(44)
-668%
(41)
+6%
(41)
0%
(25)
+39%
(23)
+10%
(107)
-369%
(108)
-1%
(117)
-9%
(134)
-15%
(74)
+45%
(108)
-46%
(105)
+3%
(55)
+47%
(50)
+10%
(15)
+71%
(5)
+66%
(27)
-434%
(21)
+22%
(22)
-7%
(24)
-8%
(21)
+14%
(11)
+48%
13
N/A
21
+63%
24
+11%
17
-29%
(7)
N/A
(11)
-70%
(6)
+45%
(6)
+6%
(9)
-48%
(19)
-122%
(132)
-590%
(184)
-39%
(220)
-20%
(221)
-1%
(127)
+42%
(102)
+20%
(80)
+22%
(75)
+6%
(80)
-6%
(123)
-54%
(114)
+7%
(166)
-46%
(155)
+7%
(90)
+42%
(90)
0%
(76)
+16%
(119)
-57%
(159)
-34%
(167)
-5%
(138)
+17%
(146)
-6%
(116)
+20%
(112)
+4%
(104)
+8%
(62)
+40%
(48)
+23%
(45)
+7%
(65)
-45%
(77)
-18%
(86)
-12%
(78)
+9%
(72)
+7%
(73)
-1%
(67)
+7%
(64)
+5%
(44)
+31%
(33)
+25%
(39)
-18%
(39)
N/A
(39)
-2%
(46)
-16%
(57)
-24%
(70)
-23%
(80)
-15%
(72)
+10%
(54)
+25%
(49)
+10%
(51)
-5%
(68)
-33%
(78)
-15%
(79)
-1%
(69)
+14%
(46)
+33%
(35)
+23%
(31)
+11%
(194)
-522%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
1
2
4
4
6
6
5
5
23
22
0
20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46
46
0
0
0
0
0
0
570
Net Issuance of Debt
(12)
5
(3)
7
9
(9)
(29)
(44)
(53)
71
69
107
153
73
122
136
58
32
(20)
(69)
(33)
(97)
(32)
(46)
(103)
(66)
(102)
(113)
(64)
(38)
(32)
(27)
(31)
(24)
(22)
12
149
281
280
324
151
25
(13)
(66)
(134)
(42)
30
70
(3)
82
109
123
191
232
188
168
209
(72)
(69)
(83)
(159)
152
131
183
201
(62)
22
(61)
(85)
40
(33)
22
98
122
442
64
180
157
(50)
264
303
288
31
37
7
(51)
77
83
11
(44)
(24)
(202)
Cash Paid for Dividends
0
0
(5)
(7)
(10)
0
(18)
(12)
(13)
0
(15)
(15)
(15)
0
(16)
(16)
(12)
0
0
(16)
(16)
0
0
(19)
(19)
0
0
(22)
(22)
0
0
(38)
(38)
(38)
(38)
0
0
(32)
(41)
(50)
(61)
(41)
(41)
(41)
(37)
(25)
(43)
(45)
(57)
(89)
(80)
(88)
(91)
(78)
(70)
(65)
(52)
(42)
(41)
(39)
(42)
(49)
(52)
(52)
(39)
(36)
(44)
(34)
(40)
(27)
(22)
(22)
(26)
0
(13)
(43)
(59)
0
(122)
(102)
(83)
(90)
(25)
(14)
(8)
0
(0)
0
0
0
0
0
Other
0
1
0
0
(0)
(1)
(1)
(1)
(2)
(2)
(3)
(4)
0
(1)
(0)
0
(1)
(2)
(2)
(2)
(1)
(1)
(0)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(0)
0
(23)
(20)
(20)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
(1)
(1)
(16)
0
(16)
(16)
(0)
0
(0)
(0)
(0)
0
0
(0)
(0)
0
(0)
0
(0)
0
(0)
(0)
(0)
0
(0)
(0)
50
0
50
50
11
0
0
(45)
Cash from Financing Activities
(12)
N/A
0
N/A
(8)
N/A
1
N/A
2
+200%
(16)
N/A
(44)
-176%
(52)
-16%
(62)
-21%
61
N/A
56
-9%
110
+97%
160
+45%
78
-51%
125
+60%
121
-4%
45
-63%
18
-61%
(22)
N/A
(87)
-303%
(50)
+42%
(113)
-126%
(48)
+58%
(67)
-38%
(125)
-87%
(87)
+30%
(123)
-41%
(136)
-11%
(87)
+36%
(60)
+31%
(54)
+11%
(64)
-19%
(69)
-8%
(63)
+10%
(61)
+3%
12
N/A
149
+1 163%
227
+52%
219
-3%
255
+16%
90
-65%
(14)
N/A
(54)
-278%
(107)
-99%
(171)
-60%
(68)
+61%
(13)
+81%
25
N/A
(60)
N/A
(7)
+89%
28
N/A
35
+22%
101
+191%
154
+53%
118
-24%
104
-12%
157
+51%
(113)
N/A
(110)
+3%
(122)
-11%
(217)
-78%
87
N/A
63
-27%
115
+82%
162
+41%
(98)
N/A
(23)
+77%
(95)
-313%
(125)
-32%
13
N/A
(55)
N/A
(1)
+99%
71
N/A
96
+34%
429
+348%
21
-95%
121
+486%
98
-19%
(172)
N/A
162
N/A
221
+36%
198
-10%
6
-97%
69
+1 127%
95
+39%
45
-53%
173
+286%
133
-23%
22
-83%
(33)
N/A
(13)
+61%
323
N/A
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
(0)
(0)
(1)
(0)
1
1
1
0
(1)
(1)
(1)
(1)
(1)
(0)
(1)
1
2
(0)
(0)
(2)
(2)
(1)
0
0
0
0
(0)
(0)
0
0
1
1
0
0
(1)
(1)
(4)
(6)
(1)
0
3
6
2
1
0
0
0
1
2
1
0
(3)
(4)
(3)
(3)
(1)
0
1
1
0
(1)
0
(1)
(0)
1
(1)
(1)
0
0
1
2
(0)
(0)
(0)
(0)
0
(0)
(1)
(1)
(1)
(1)
(1)
(1)
Net Change in Cash
(1)
N/A
(4)
-193%
7
N/A
(10)
N/A
25
N/A
3
-88%
12
+294%
9
-27%
25
+184%
21
-17%
(11)
N/A
13
N/A
(1)
N/A
39
N/A
8
-79%
(7)
N/A
17
N/A
(41)
N/A
19
N/A
32
+65%
(12)
N/A
(1)
+94%
(11)
-1 300%
27
N/A
38
+42%
27
-30%
61
+129%
(18)
N/A
10
N/A
15
+50%
15
-1%
(26)
N/A
(1)
+95%
(17)
-1 129%
(40)
-133%
(1)
+97%
(48)
-4 264%
29
N/A
(27)
N/A
11
N/A
(21)
N/A
(54)
-161%
(18)
+67%
(22)
-25%
(2)
+93%
7
N/A
3
-57%
24
+656%
(1)
N/A
2
N/A
(5)
N/A
(22)
-363%
(9)
+57%
(3)
+64%
6
N/A
16
+172%
48
+203%
(9)
N/A
11
N/A
(16)
N/A
(43)
-168%
23
N/A
(5)
N/A
6
N/A
3
-47%
(3)
N/A
6
N/A
9
+52%
(8)
N/A
(10)
-24%
(7)
+29%
(2)
+79%
13
N/A
29
+121%
34
+19%
17
-50%
11
-33%
73
+551%
(26)
N/A
(21)
+20%
6
N/A
(75)
N/A
(7)
+91%
3
N/A
75
+2 493%
23
-69%
33
+39%
30
-8%
19
-38%
52
+179%
83
+59%
120
+45%
Free Cash Flow
Free Cash Flow
11
N/A
(8)
N/A
(1)
+90%
(7)
-713%
44
N/A
40
-10%
77
+94%
61
-21%
96
+57%
47
-51%
20
-57%
(10)
N/A
(77)
-679%
(27)
+65%
(97)
-253%
(108)
-12%
(40)
+63%
(70)
-74%
21
N/A
99
+377%
38
-61%
113
+197%
37
-67%
93
+153%
161
+72%
105
-35%
156
+49%
84
-46%
44
-48%
29
-34%
41
+42%
16
-61%
67
+316%
44
-34%
19
-56%
(18)
N/A
(96)
-420%
(48)
+50%
(56)
-18%
(40)
+30%
(6)
+85%
38
N/A
84
+120%
129
+53%
207
+61%
156
-24%
96
-38%
117
+22%
182
+55%
67
-63%
21
-69%
(33)
N/A
(54)
-64%
(66)
-22%
(13)
+80%
10
N/A
(8)
N/A
173
N/A
189
+10%
169
-11%
210
+24%
(32)
N/A
(40)
-25%
(65)
-62%
(100)
-54%
162
N/A
90
-45%
161
+78%
169
+5%
25
-85%
92
+272%
25
-73%
(35)
N/A
(45)
-28%
(372)
-734%
20
N/A
(94)
N/A
(10)
+90%
164
N/A
(162)
N/A
(202)
-24%
(260)
-29%
(5)
+98%
(59)
-1 190%
(16)
+72%
(11)
+36%
(123)
-1 071%
(88)
+29%
12
N/A
93
+704%
102
+10%
(39)
N/A

See Also

Summary
PHARMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHARMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHARMA stock valuation using valuation multiples.
Wall Street Estimates
PHARMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHARMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.